Related Experiment Videos
[Establishment of detection test for hepatitis C virus antigen]
1The National Institute for the Control of Pharmaceutical and Biological Products, Key Laboratory of Ministry of Public Health for Control and Standardization of Biotech Products, Beijing 100050, China.
Summary
A new enzyme-linked immunosorbent assay (ELISA) can detect hepatitis C virus (HCV) antigen in plasma. This method is crucial for HCV research and preventing transmission.
Area of Science:
- Virology
- Immunology
- Biotechnology
Context:
- Hepatitis C virus (HCV) infection remains a significant global health concern.
- Accurate and sensitive detection methods are vital for diagnosis and management.
- Current diagnostic approaches may have limitations in early detection.
Purpose:
- To develop and validate an enzyme-linked immunosorbent assay (ELISA) for detecting HCV antigen.
- To optimize monoclonal antibody (McAb) combinations for enhanced sensitivity.
- To assess the feasibility of direct HCV antigen detection in plasma and serum samples.
Summary:
- An optimized ELISA utilizing specific monoclonal antibodies (McAbs) was established for HCV antigen detection.
- The assay demonstrated a detection limit of 5 ng/ml for C7 antigen.
- Out of 371 screened samples, 27 were positive for HCV antigen, with 23 confirmed positive for HCV RNA by PCR.
Impact:
- This assay enables direct detection of HCV antigen in plasma, including in anti-HCV negative samples.
- The findings support the potential for improved HCV diagnostics.
- The developed test is important for fundamental HCV research and controlling viral transmission.